CIK 0001388658 · Large accelerated filer
iRhythm Holdings, Inc.
Sign in to watch- Ticker
- IRTC
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 413421287
- Phone
- 415-632-5700
- Business address
- 699 8TH STREET, SUITE 600, San Francisco, CA, 94103
- Former names
- IRhythm Technologies, Inc., iRhythm Technologies, Inc., IRhythm Technologies Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $94,175
- in 1 filing
Net −$94,175. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-25 | Blackford Quentin S. President and CEO | Sale | −25,540 | $135.42 | $3.5M | 186,126 |
| 2026-02-24 | Smith Mervin EVP Strategic Business Ops | Grant or award | +9,210 | 24,316 | ||
| 2026-02-24 | Turakhia Minang CHIEF MED/SCI OFCR EVP ADVTECH | Grant or award | +15,060 | 56,703 | ||
| 2026-02-24 | Rosenbaum Marc Wade Chief Accounting Officer | Grant or award | +9,210 | 19,811 | ||
| 2026-02-24 | Wilson Daniel G. Chief Financial Officer | Grant or award | +9,412 | 35,882 | ||
| 2026-02-24 | Shrishrimal Sumi EVP, Chief Risk Officer | Grant or award | +11,294 | 45,399 | ||
| 2026-02-24 | Patterson Chad CHIEF COMM & PRODUCT OFFICER | Grant or award | +17,318 | 60,705 | ||
| 2026-02-24 | Murphy Patrick Michael CBO and CLO | Grant or award | +15,060 | 68,341 | ||
| 2026-02-24 | Blackford Quentin S. President and CEO | Grant or award | +46,687 | 211,666 | ||
| 2026-02-24 | Smith Mervin EVP Strategic Business Ops | Sale 10b5-1 | −732 | $140.91 | $103K | 15,106 |
| 2026-02-24 | Rosenbaum Marc Wade Chief Accounting Officer | Sale 10b5-1 | −280 | $140.91 | $39K | 10,601 |
| 2026-02-23 | TALWALKAR ABHIJIT Y Director | Option exercise 10b5-1 | +5,312 | $10.71 | $57K | 25,611 |
| 2026-02-23 | TALWALKAR ABHIJIT Y Director | Sale 10b5-1 | −1,378 | $143.40 | $198K | 24,233 |
| 2026-02-23 | TALWALKAR ABHIJIT Y Director | Sale 10b5-1 | −1,725 | $145.32 | $251K | 22,508 |
| 2026-02-23 | TALWALKAR ABHIJIT Y Director | Sale 10b5-1 | −572 | $146.95 | $84K | 21,936 |
| 2026-02-23 | TALWALKAR ABHIJIT Y Director | Sale 10b5-1 | −1,637 | $147.62 | $242K | 20,299 |
| 2026-02-23 | TALWALKAR ABHIJIT Y Director | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,312 | $10.71 | $57K | 5,312 |
| 2025-12-02 | Patterson Chad CHIEF COMM & PRODUCT OFFICER | Sale 10b5-1 | −280 | $184.83 | $52K | 43,387 |
| 2025-12-02 | Murphy Patrick Michael CBO and CLO | Sale | −2,478 | $184.83 | $458K | 53,281 |
| 2025-11-28 | Turakhia Minang CHIEF MED/SCI OFCR EVP ADVTECH | Grant or award | +250 | $74.72 | $19K | 41,643 |
Page 5 of 8 · 159 trades